New collaboration brings RoosterBio's high-quality Research-Grade and CliniControl™ cGMP Media Platforms to China's top cell and gene therapy firms. MineBio has secured import authorization, enabling swift order processing. From Frederick, Md., the partnership was announced on April 8, 2026. This move extends RoosterBio, Inc.'s reach to a significant market and presents immediate fulfillment opportunities.